Werkgroep Cardiologische centra Nederland

GALACTIC HF (Follow-up)

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction
Medicine
omecamtiv mecarbil
Population
Heart failure
Phase
III
Starting year
2016
More information
ClinicalTrials.gov

Director of Study

dr. J. Schaap (Cardioloog)
Breda, Amphia Ziekenhuis